Ludwig Cancer Research and CRI initiate clinical trial of immunotherapy for ovarian cancer
Ludwig Cancer Research and the Cancer Research Institute (CRI) have launched a Phase 1/2 clinical trial of combination immunotherapy for advanced ovarian cancer. The international, multicenter trial is led by George Coukos, ...
Apr 6, 2016
0
8